Blood Cancer Journal · 2015 · 19 citations · 21 references
Life SciencesGeneticsHematologyCytogeneticsHematologic OncologyStem Cell TransplantationCancer CytogeneticsChromosome AberrationsClinical CytogeneticsHematopoietic Stem Cell TransplantationHematopoietic Stem CellsMolecular CytogeneticsAcute LeukemiasAutosomal MonosomyBiological PrognosisChromosomal Abnormality DetectionKaryotypic AbnormalitiesLeukemia ClassificationLeukemia CytogeneticsMetaphase Cytogenetics
Monosomal karyotype (MK) defined by either ⩾2 autosomal monosomies or single monosomy with at least one additional structural chromosomal abnormality is associated with a dismal prognosis in patients with acute myeloid leukemia (AML). It was detected in 174 of 3041 AML patients in South Korean Registry. A total of 119 patients who had received induction therapy were finally analyzed to evaluate the predictive factors for a positive prognosis. On multivariate analysis, single monosomy, the absence of abn(17p), ⩾10% of cells with normal metaphase and the achievement of a complete remission (CR) after induction therapy were significant factors for more favorable outcomes. Especially, single monosomy remained as a significantly independent prognostic factor for superior survival in both patients who received allogeneic hematopoietic stem cell transplantation (allo-HSCT) in CR and who did not. Allo-HSCT in CR improved overall survival significantly only in patients with a single monosomy. Our results suggest that MK-AML may be biologically different according to the karyotypic subtype and that allo-HSCT in CR should be strongly recommended to patients with a single monosomy. For other patients, more prudent treatment strategies should be examined. Furthermore, the biological mechanism by which a single monosomy influences survival should be investigated.
21
David Grimwade, Robert K. Hills, Anthony V. Moorman et al. · Blood · 2010 · 2K citations · Full text
Life Sciences, Hematology, Oncology +16
Marilyn L. Slovak, Kenneth J. Kopecky, Peter A. Cassileth et al. · Blood · 2000 · 1.6K citations
Medicine, Hematology, Oncology +10
Jan J. Cornelissen, Wim L.J. van Putten, Leo F. Verdonck et al. · Blood · 2007 · 470 citations · Full text
Medicine, Hematology, Oncology +17